DHR vs GEV: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and GE Vernova Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-25.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
GE Vernova Inc. · Industrials
$1,014.75
-16.2% upside to fair value
Med Conviction
Grade C+
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
GEV trades at a lower forward P/E
(34.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
GEV |
| Current Price |
$195.98 |
$1,014.75 |
| Fair Value Estimate |
$211.54 |
$850.00 |
| Upside to Fair Value |
+7.9%
|
-16.2%
|
| Market Cap |
$138.7B |
$270.3B |
| Forward P/E |
37.8x
|
34.3x
|
| EV / EBITDA |
22.8x
|
25.6x
|
| Price / Sales |
5.6x
|
6.6x
|
| Price / FCF |
26.2x
|
22.0x
|
| Revenue Growth YoY |
+3.7%
|
+15.0%
|
| Gross Margin |
60.7%
|
21.3%
|
| Operating Margin |
21.0%
|
5.9%
|
| Return on Equity |
7.1%
|
30.0%
|
| Dividend Yield |
0% |
0.17% |
| FCF Yield |
3.81%
|
4.5%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
GE Vernova is the premier pure-play on the electricity side of the AI infrastructure supercycle. Its Power (heavy-duty gas turbines) and Electrification (grid equipment) segments are structurally supply-constrained, backed by a record $176B backlog that management says is 'mostly sold out through 2030.' The company raised FY2026 guidance for a second straight quarter to $45.5-46.5B revenue and $1…
Accumulation Zones
| Metric |
DHR |
GEV |
| Zone Low |
$158.66 |
$640.00 |
| Zone High |
$179.81 |
$723.00 |
| In Buy Zone? |
No
|
No
|